Mavenclad benefits for MS sustained up to 15 years after last treatment

[KoKo]

The benefits of Mavenclad (cladribine) were sustained for up to 15 years after its last treatment course in people with relapsing multiple sclerosis (MS), according to real-world data from the CLASSIC-MS study.

More than half of those who received the oral therapy in the clinical trials that supported its approval no longer needed further disease-modifying therapies (DMTs) and twice as many continued relapse-free over a median of 10.9 years compared with those never given it.


Mavenclad benefits for MS sustained up to 15 years after last treatment | Multiple Sclerosis News Today

[limppy]

Great news I am coming up on 4 years since taking mavenclad and taking no DMT I am on medicare so insurance is crappy ..

[KoKo]

Hey limppy!

Thanks for sharing your experience.

Wishing you the very best outcome from your Mavenclad treatment.

Please continue to keep us posted on how you're doing.

Thank you limppy!